Literature DB >> 1154362

W4(4a) and W6(4b) in diverse human populations. Demonstration of their genetic identity in population and segregation studies.

J D'Amaro.   

Abstract

The status of the W4, W6 system as related to the HL-A system was re-evaluated by means of segregation and mating studies in 200 Dutch families with 755 children. Inclusion analyses were performed on the Fifth Workshop human populations and related to a reference analysis on the main file in Leiden. The results of the mating and segregation analyses showed a good fit for W4 and W6 as a genetic system. The inclusion analyses showed a high degree of concordance. Based on those results, and other cited evidence, it was suggested that W4 and W6 may represent the basic substance of the HL-A antigens in the FOUR series.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1154362     DOI: 10.1111/j.1399-0039.1975.tb01482.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  5 in total

1.  Histocompatibility matching and renal graft survival.

Authors:  R T Oliver
Journal:  Proc R Soc Med       Date:  1976-07

2.  Linkage of GLO with HLA in a sample of the Spanish population.

Authors:  C Lopez-Larrea; A Bootello; A Arnaiz-Villena
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

3.  HLA antigens in a sample of the Spanish population: common features among Spaniards, Basques, and Sardinians.

Authors:  A Arnaiz-Villena; S Rodriguez de Córdoba; F Vela; J C Pascual; J Cerveró; A Bootello
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate.

Authors:  P Parham
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family.

Authors:  E Nossner; J E Goldberg; C Naftzger; S C Lyu; C Clayberger; A M Krensky
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.